194 related articles for article (PubMed ID: 7330973)
1. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
Festenstein H; de Giorgi L; Matossian-Rogers A
Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
[No Abstract] [Full Text] [Related]
2. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
3. MHC-coded unique alloantigens and antitumor immunity.
Martin WJ
Transplant Proc; 1981 Dec; 13(4):1837-40. PubMed ID: 7036480
[No Abstract] [Full Text] [Related]
4. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
Imamura M; Martin WJ
J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
[No Abstract] [Full Text] [Related]
5. Influence of class I H-2 gene expression on local tumor growth. Description of a model obtained from clones derived from a solid BALB/c tumor.
Garrido A; Pérez M; Delgado C; Garrido ML; Rojano J; Algarra I; Garrido F
Exp Clin Immunogenet; 1986; 3(2):98-110. PubMed ID: 3274051
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
Parmiani G; Ballinari D; Sensi ML
J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
[No Abstract] [Full Text] [Related]
7. A syngeneic anti tumor serum recognizing a complex H-2 alloantigen.
Garrido F; Perez M; Torres MD; Garcia-Olivares E; Ivanyi P; Schirrmacher V
Immunobiology; 1979 Aug; 156(1-2):110-20. PubMed ID: 540966
[TBL] [Abstract][Full Text] [Related]
8. Biochemical evidence for expression of a semi-allogeneic, H-2 antigen by a murine adenocarcinoma.
Callahan GN; Pardi D; Giedlin MA; Allison JP; Morizot DM; Martin WJ
J Immunol; 1983 Jan; 130(1):471-9. PubMed ID: 6847892
[TBL] [Abstract][Full Text] [Related]
9. Relationship between foreign H-2-like antigens on MCG4 sarcoma and the in vivo rejection of this tumor by syngeneic and semisyngeneic mice.
García-Olivares E; Torres MD; Gutiérrez F; Osorio C
Rev Esp Fisiol; 1982 Mar; 38(1):9-12. PubMed ID: 7100610
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype.
Steinmuller D; Tyler JD; David CS
J Immunol; 1981 May; 126(5):1747-53. PubMed ID: 6452477
[No Abstract] [Full Text] [Related]
11. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mouse tumor cells in vitro by contact with lymph node and tumor cells containing foreign H-2 antigens.
Hellström KE; Hellström I
Fed Proc; 1968; 27(1):39-41. PubMed ID: 4952629
[No Abstract] [Full Text] [Related]
13. Tumor cell-specific transcription of a murine histocompatibility class Ib Q5 gene.
Noguchi K; Kuwada E; Goto S; Egawa K
Anticancer Res; 2004; 24(5C):3379-86. PubMed ID: 15515435
[TBL] [Abstract][Full Text] [Related]
14. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
15. Anomalous behavior of H-2Kb in immunity to syngeneic SV40 transformed cells: evidence for cytotoxic T cell recognition of H-2/SV40 membrane antigen complexes.
Gooding LR
J Immunol; 1980 Apr; 124(4):1612-9. PubMed ID: 6245126
[No Abstract] [Full Text] [Related]
16. Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL.
Schirrmacher V; Garrido F; Hübsch D; Garcia-Olivares E; Koszinowski U
Transplant Proc; 1980 Mar; 12(1):32-7. PubMed ID: 6154357
[No Abstract] [Full Text] [Related]
17. Different H-2 antigens expressed on two tumors derived from one BALB/c mouse.
Garrido F; Perez M; Iványi P; Schirrmacher V
Transplant Proc; 1981 Dec; 13(4):1824-7. PubMed ID: 7330970
[No Abstract] [Full Text] [Related]
18. Obtention of 7 ascites tumor lines expressing H-2s and not H-2k from a C3H-specific polyoma-induced solid tumor.
Robert F; Oth D; Berebbi M
Transplant Proc; 1981 Dec; 13(4):1828-32. PubMed ID: 6277057
[No Abstract] [Full Text] [Related]
19. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
Arora PK; Shearer GM
J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
[No Abstract] [Full Text] [Related]
20. Analysis of lymphoid cells responding to virus- and tumor-associated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials.
Lopez DM; Paul RD
J Natl Cancer Inst; 1982 Dec; 69(6):1403-9. PubMed ID: 6292565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
